Winners
We are proud to share our Prix Galien Hall of Fame below. In addition to highlighting the products and companies, our EBook of Innovation chronicles the R&D team members responsible for the development of each Prix Galien award-winning product. The resulting of this effort will be an opportunity for patients who have been treated by the winning innovations to communicate with the R&D teams responsible for their improved health. If you were a member of the research team for any of the products below please confidentially share your contact information here to receive a welcome pack, including a certificate of recognition for your work from the Galien Foundation, and an introduction to this community
| MEDICAL FIELD | YEAR | NAME | COMPANY | COUNTRY |
|---|---|---|---|---|
| SPECIALITES | ANNEE | DESIGNATION | LABORATOIRE | PAYS |
| Winner Medicines Orphan Drugs | 2019 | Kymriah and Luxturna | Novartis | FRANCE |
| Winner Medicines Orphan Drugs | 2019 | Yescarta | Gilead( Kite) | FRANCE |
| Winner Medicines Orphan Drugs | 2019 | Dupixent | Sanofi | FRANCE |
| MEDICAL TECHNOLOGY | 2019 | EarlySense | Devices4Care | NETHERLANDS |
| RESEARCH | 2019 | Prof. Dr. Jeffrey Beekman, Professor of Cellular Disease Models, Pediatric Pulmonology | UMC Utrecht | NETHERLANDS |
| RARE DISEASE | 2019 | Onpattro® (patisiran) | Alnylam Pharmaceuticals | NETHERLANDS |
| RARE DISEASE | 2019 | Onpattro® (patisiran) | Alnylam Pharmaceuticals | ITALY |
| INFECTIOUS DISEASE | 2019 | Zostavax® (Herpes Zoster vaccine) | MSD | ITALY |
| HEMOPHILIA | 2019 | Hemlibra (emicizumab) | Roche | ITALY |
| ONCOLOGY | 2019 | Kisqali® (ribociclib) | Novartis | ITALY |
| OPHTHALMOLOGY | 2019 | Luxturna® (voretigene neparvovec) | Novartis | ITALY |
| Vaccinology | 2019 | SHINGRIX | GSK | CANADA |
| Winner Medicines Orphan Drugs | 2019 | YESCARTA | GILEAD / KITE | GERMANY |
| Winner Medicines Orphan Drugs | 2019 | KYMRIAH | NOVARTIS | GERMANY |
| Winner Medicines Specialist Care | 2019 | REAGILA | RECORDATI PHARMA | GERMANY |
| Winner Medicines Primary Care | 2019 | SHINGRIX | GSK | GERMANY |
| Research Achievement in Clinical or Experimental Pharmacology | 2019 | Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in in fully immunocompetent allogeneic recipients | Sonja Schrepfer, MD, PhD, Professor of Surgery, University Heart Center Hamburg Transplant and Stem Cell Immunobiology Lab | GERMANY |
| Vaccinology | 2019 | SHINGRIX | GSK | USA |
| Ophthalmology | 2019 | LUXTURNA™ (voretigene neparvovec-rzyl) | Spark Therapeutics | USA |
| Medical Technology | 2019 | FreeStyle® Libre 14 Day Flash Glucose Monitoring System | Abbott | USA |
| Medical Devices Prize Laureate | 2019 | Magseed/Magtrace | Sysmex | BELGIUM / LUXEMBURG |
| Prize medicin | 2019 | Kymriah® (tisagenlecleucel) | Novartis | BELGIUM / LUXEMBURG |
| Prize medicin | 2019 | Yescarta® (axicabtagene ciloleucel) | Gilead | BELGIUM / LUXEMBURG |
| Prize Farmacology | 2019 | Study: Tumor cell metabolism: new therapeutic opportunities from microenvironmental acidosis | Dr Cyril Corbet - UCLouvain | BELGIUM / LUXEMBURG |
| Spinal Muscular Atrophy (SMA) | 2019 | Spinraza (nusinersen) | Biogen | SWITZERLAND |
| 2019 | RYDAPT (midostaurin, formerly PKC412) | Novartis | SWITZERLAND | |
| 2019 | Jardiance | Boehringer-Ingelheim | SWITZERLAND | |
| BEST PHARMACEUTICAL PRODUCT | 2019 | LYMPARZA (Olaparib) | ASTRAZENECA | GREECE |
| BEST PHARMACEUTICAL PRODUCT | 2019 | ZAVICEFTA (Ceftazidime-avibactam) | PFIZER HOSPITAL | GREECE |
| BEST BIOTECHNOLOGY PRODUCT | 2019 | KYMRIAH(Tisagenlecleucel) | NOVARTIS | GREECE |
| BEST PRODUCT FOR RARE DISEASE | 2019 | ADCETRIS (Brentuximab Vedotin) | TAKEDA ONCOLOGY | GREECE |
| BEST MEDICAL TECHNOLOGY PRODUCT | 2019 | FOUNDATIONONE CDX - FOUNDATIONONE LIQUID | ROCHE | GREECE |
| BEST MEDICAL TECHNOLOGY PRODUCT | 2019 | POMPOTIKO XEIPOYPGIKO SYSTHMA DA VINCI XILOPOPMA 4TH GENIA | SOFMEDICA | GREECE |
| PHARMACEUTICAL PRODUCT | 2019 | TAGRISSO (Osimertinib) | ASTRAZENECA (Discovery of the Last Five Years) | GREECE |
| BIOTECHNOLOGY PRODUCT | 2019 | KEYTRUDA (Pembrolizumab) | MSD (Discovery of the Last Five Years) | GREECE |
| PRODUCT FOR RARE DISEASE | 2019 | OFEV (Nintedanib) | BOEHRINGER INGELHEIM (Discovery of the Last Five Years) | GREECE |
| MEDICAL TECHNOLOGY PRODUCT | 2019 | NEXARIS ANGIO-CT-MR | SIEMENS HEALTHINEERS(Discovery of the Last Five Years) | GREECE |
| BEST PHARMACEUTICAL PRODUCT | 2019 | LYMPARZA (Olaparib) | MSD | GREECE |
| CARDIOLOGY | 2018 | ENTRESTO | NOVARTIS | SWITZERLAND |
| ONCOLOGY | 2018 | OPDIVO (Nivolumab) | BRISTOL-MYERS SQUIBB | SWITZERLAND |
| MEDICAL TECHNOLOGY | 2018 | URGOSTART | URGO MEDICAL | FRANCE |
| MEDICAL TECHNOLOGY | 2018 | MICI CONNECT | Association AFA Crohn RCH France | FRANCE |
| Patient Support | 2018 | 20Ans 1Projet | 20Ans 1Projet | FRANCE |
| HEMOPHILIA | 2018 | Hemlibra (émicizumab) | Roche & Chugai Pharma | FRANCE |
| Spinal Muscular Atrophy (SMA) | 2018 | Spinraza (nusinersen) | Biogen | FRANCE |
| Research | 2018 | PRIMA | Pixium Vision | FRANCE |
| Research | 2018 | Replacement of airways with an aortic matrix temporarily supported by a stent | Emmanuel Martinod | FRANCE |
| ONCOLOGY | 2018 | Yescarta | Kite, a Gilead Company | USA |
| ONCOLOGY | 2018 | Kymriah | Novartis | USA |
| HEMATOLOGY/ONCOLOGY | 2018 | IDHIFA | Celgene-Agios | USA |
| TECHNOLOGY | 2018 | WATCHMAN | Boston Scientific | USA |
| 2018 | Galafold | Amicus | UK | |
| 2018 | Amicus | Medtronic | UK | |
| 2018 | Spinraza | Biogen | UK | |
| Best Medical Technology | 2018 | Autotest VIH | AAZ-LMB | INTERNATIONAL |
| Best Biotechnology Product | 2018 | Spinraza. | Biogen | INTERNATIONAL |
| Best Pharmaceutical Product. | 2018 | Jardiance | Boehringer Ingelheim | INTERNATIONAL |
| 2018 | Zinplava (Bezlotoxumab) | MSD Sharpe & Dohme | GERMANY | |
| HEMOPHILIA | 2018 | Hemlibra (Emicizumab) | Roche & Chugai | GERMANY |
| RESEARCH | 2018 | Peter Kühnen & Heike Biebermann for research on leptin receptor deficiency | Charité University Medical Center, Berlin | GERMANY |
| OPHTHALMOLOGY | 2018 | Holoclar | Chiesi | GERMANY |
| SPINAL MUSCULAR ATROPHY (SMA) | 2018 | Spinraza (Nusinersen) | Biogen | GERMANY |
| CARDIOLOGY | 2018 | Sacubitril / Valsartan (Entresto) | Novartis Pharmaceuticals | CANADA |
| Spinal Muscular Atrophy (SMA) | 2017 | Spinraza | Biogen & Ionis Pharmaceuticals | USA |
| ONCOLOGY | 2017 | Venclexta (venetocla x) tablets | AbbVie & Genentech (a Member of the Roche Group) | USA |
| NEUROLOGY | 2017 | Exablate Neuro | INSIGHTEC | USA |
| CARDIOLOGY | 2017 | REPATHA (Evolocumab) | AMGEN | SWITZERLAND |
| OPHTHALMOLOGY | 2017 | HOLOCLAR | CHIESI | NETHERLANDS |
| IMMUNOLOGY | 2017 | STRIMVELIS | GSK | NETHERLANDS |
| IMMUNOLOGY | 2017 | For research on the endocannabinoid system | Mario van der Stelt, University of Leiden | NETHERLANDS |
| VACCINOTHERAPY | 2017 | GARDASIL 9 (9 valent vaccine for human papillomavirus) | MSD | ITALY |
| NEUROLOGY | 2017 | FINGOLIMOD (Gilenya) | Novartis | ITALY |
| IMMUNOLOGY | 2017 | OCALIVA (obeticholic acid) | Intercept Pharmaceuticals | ITALY |
| IMMUNOLOGY | 2017 | STRIMVELIS (autologe CD34+ cells transduced for human adenosinedeaminas) | GSK | ITALY |
| HEMATOLOGY | 2017 | Praxbind (Idarucizumab) | Boehringer Ingelheim | ITALY |
| IMMUNOLOGY | 2017 | GILENYA (fingolimod) | Novartis | ITALY |
| VACCINOTHERAPY | 2017 | GARDASIL 9 (papillomavirus vaccine) | MSD | ITALY |
| RARE DISEASES | 2017 | OFEV (Nintedanib) | Boehringer Ingelheim | GREECE |
| ONCOLOGY | 2017 | TAGRISSO (Osimertinib) | AstraZeneca | GREECE |
| ONCOLOGY | 2017 | KEYTRUDA (Pembrolizumab) | Merck Sharp & Dohme (MSD) | GREECE |
| ONCOLOGY | 2017 | OPDIVO (Nivolumab) | Bristol Myers Squibb | GREECE |
| MEDICAL TECHNOLOGY | 2017 | Cobas® EGFR Mutation Test v2 | Roche Diagnostics (Hellas) | GREECE |
| PULONOLOGY | 2017 | Cinqaero ( Reslizumab) | TEVA | GERMANY |
| ONCOLOGY | 2017 | Venclexta (venetoclax) tablets | AbbVie | GERMANY |
| CARDIOLOGY | 2017 | Entresto (Sacubitril /Valsartan) | Novartis | GERMANY |
| 2017 | Immuno modulatory drugs disrupt the cereblon-CD147-MCT1 axis to exertantitumor activity and teratogenicity | Prof. Dr. Florian Bassermann, Technical University | GERMANY | |
| ORTHOPEDICS | 2017 | EOS | EOS imaging | FRANCE |
| ONCOLOGY | 2017 | DARZALEX (Daratumumab) | JANSSEN | FRANCE |
| GASTROENTEROLOGY | 2017 | REVESTIVE (Teduglutide) | SHIRE | FRANCE |
| E-HEALTH | 2017 | My Notebook AVK | Faculty of Pharmacy of Angers | FRANCE |
| DERMATOLOGY | 2017 | Clairial Serum | SVR | FRANCE |
| DERMATOLOGY | 2017 | Research on the role of cutaneous microvasculature in pigmentation | Pr Thierry Passeron, University of Nice Sophia Antipolis | FRANCE |
| CARDIOLOGY | 2017 | ENTRESTO (Sacubitril, Valsartan) | NOVARTIS | FRANCE |
| PATIENT CARE | 2017 | CHEER UP | Fédération Cheer Up | FRANCE |
| ONCOLOGY | 2017 | PEMBROLIZUMAB (Keytruda) | Merck | CANADA |
| 2017 | for elucidating the differential beneficial effects of ACE inhibitors, angiotension receptor antagonists, mineralocorticoid receptor blockers, and calcium channel antagonists in hypertension and diabetes | Dr. Ernesto Schiffrin, McGill University | CANADA | |
| SPINAL MUSCULAR ATROPHY (SMA) | 2017 | Spinraza® (Nusinersen) | Biogen | BELGIUM |
| PHARMACOLOGY | 2017 | Mathieu Vinken for research on new pharmacological targets for liver treatment | Vrije Universiteit Brussel-Belgium | BELGIUM |
| MEDICAL TECHNOLOGY | 2017 | BD Phoenix™ CPO detect | BD | BELGIUM |
| ONCOLOGY | 2016 | IBRANCE (palbociclib) | PFIZER | USA |
| ONCOLOGY | 2016 | GLEEVEC (imatinib) | NOVARTIS (Discovery of the Decade) | USA |
| ONCOLOGY | 2016 | YERVOY (Ipilimumab) | BRISTOL-MYERS SQUIBB (Discovery of the Decade) | USA |
| MEDICAL TECHNOLOGY | 2016 | SAPIEN3 Transcatheter Heart valve | EDWARDS LIFESCIENCES (Discovery of the Decade) | USA |
| MEDICAL TECHNOLOGY | 2016 | COLOGUARD | EXACT SCIENCES | USA |
| DERMATOLOGY | 2016 | COSENTYX | NOVARTIS | USA |
| OPHTHALMOLOGY | 2016 | Ex vivo expanded autologous human corneal epithelial cells | CHIESI | UNITED KINGDOM |
| CARDIOLOGY | 2016 | SACUBITRIL: VALSARTAN (Entresto) | NOVARTIS | UNITED KINGDOM |
| DERMATOLOGY | 2016 | SECUKINUMAB (Cosentyx) | NOVARTIS PHARMA | SWITZERLAND |
| ONCOLOGY | 2016 | IMBRUVICA (Ibrutinib) | JANSSEN | RUSSIA |
| ONCOLOGY | 2016 | BLINATUMOBAB | AMGEN | RUSSIA |
| ONCOLOGY | 2016 | YERVOY (Ipilimumab) | BRISTOL-MYERS SQUIBB | RUSSIA |
| OBSTETRICS/GYNECOLOGY | 2016 | "Femoflor"&"ImmunoQuantex" for differential and complex diagnosis of different clinical condition connected with dysbiotic disorders and inflammatory conditions of the lower reproductive tract of women | DNA-Technology and Federal State Budget Institution "Research Center for Obstetrics, Gynecology and Perinatology" Ministry of Healthcare of the Russian Federation | RUSSIA |
| INFECTIOLOGY | 2016 | Work on the development of a new generation of antivirals of the family of azoloazines | Valery Charushin, Oleg Chupakhin and Vladimir Rusinov | RUSSIA |
| CARDIOLOGY | 2016 | ABSORB Bioresorbable Vascular Scaffold | ABBOTT | RUSSIA |
| OSTEOLOGY | 2016 | Work on a new generation, bone-replacement implanting biomaterial for regenerative medicine ("artificial bone") | Prof. Grażyna Ginalska | POLAND |
| ONCOLOGY | 2016 | BLINATUMOMAB | AMGEN | POLAND |
| ONCOLOGY | 2016 | IMBRUVICA (Ibrutinib) | JANSSEN | POLAND |
| ONCOLOGY | 2016 | PEMBROLI ZUMAB (Keytruda) | MERCK | POLAND |
| INFECTIOLOGY | 2016 | 9-valent vaccine against human papillomavirus (recombined, adsorbed) | MSD | POLAND |
| CARDIOLOGY | 2016 | Servier for the Heart preventive educational campaign | Servier Polska | POLAND |
| CARDIOLOGY | 2016 | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM | POLAND |
| OPHTHALMOLOGY | 2016 | Ex vivo expanded autologous human corneal epithelial cells | CHIESI | NETHERLANDS |
| ENDOCRINOLOGY | 2016 | Works on specialized medicine for patients with diabetes or kidney disease | Dr Hiddo Lambers Heerspink (universit de Groningen) | NETHERLANDS |
| PNEUMOLOGY | 2016 | SIRTURO (Bedaquiline) | JANSSEN | INTERNATIONAL |
| ONCOLOGY | 2016 | PEMBROLI ZUMAB (Keytruda) | MERCK | INTERNATIONAL |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2016 | ORPHACOL (cholic acid) | CTRS | INTERNATIONAL |
| ENDOCRINOLOGY | 2016 | KANUMA (sebelipase alfa) | ALEXION | GERMANY |
| RESEARCH AND DEVELOPMENT | 2016 | Thérapie cellulaire de l’insuffisance cardiaque | Équipe du Pr Philippe Menasché et du Pr Jérôme Larghero | FRANCE |
| PNEUMOLOGY | 2016 | ORKAMBI | VERTEX | FRANCE |
| PHARMACEUTICAL PRODUCT | 2016 | OPDIVO (Nivolumab) | BMS | FRANCE |
| PHARMACEUTICAL PRODUCT | 2016 | ORKAMBI (Lumacaftor-Ivacaftor) | VERTEX PHARMACEUTICALS | FRANCE |
| PHARMACEUTICAL PRODUCT | 2016 | SELINCRO (Nalméfène) | LUNDBECK | FRANCE |
| PHARMACEUTICAL PRODUCT | 2016 | KEYTRUDA (Pembrolizumab) | MSD | FRANCE |
| PHARMACEUTICAL PRODUCT | 2016 | TRANSLARNA (Ataluren) | PTC THERAPEUTICS | FRANCE |
| PATIENT CARE | 2016 | KOLIBRI | Association L'ENFANT@L'HÔPITAL | FRANCE |
| PATIENT CARE | 2016 | Accompagnement des parents dans l’apprentissage du traitement par dialyse péritonéale (DP) de leur enfant en insuffisance rénale chronique terminale | Service de néphrologie pédiatrique et équipe d’hospitalisation à domicile, à Hôpital Robert-Debré (Paris) | FRANCE |
| ONCOLOGY | 2016 | FOCAL ONE | EDAP TMS | FRANCE |
| NEUROMUSCULAR DISEASES | 2016 | ATALUREN (Translarna ™) | PTC Therapeutics | FRANCE |
| MEDICAL TECHNOLOGY | 2016 | Autotest de dépistage du VIH | AAZ | FRANCE |
| MEDICAL TECHNOLOGY | 2016 | Système de traitement des plaies par pression négative à usage unique PICO | SMITH & NEPHEW | FRANCE |
| MEDICAL TECHNOLOGY | 2016 | Dispositif dédié à la thérapie locale du cancer de la prostate, FOCAL ONE | EDAP TMS | FRANCE |
| INFECTIOLOGY | 2016 | AUTOTEST VIH | AAZ | FRANCE |
| E-HEALTH | 2016 | MESVACCINS.NET | GROUPE D’ETUDES EN PRÉVENTOLOGIE & SYADEM | FRANCE |
| DEVICE | 2016 | PICO | SMITH & NEPHEW | FRANCE |
| DERMATOLOGICAL COSMETICS & AESTHETIC DERMATOLOGY | 2016 | Traitement des radiodermites par laser à colorant pulsé | Dr Jean-Michel Mazer | FRANCE |
| IMMUNOLOGY | 2016 | Work on drastic reduction of transplantation failure rates | Dr. Philip F Halloran | CANADA |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2016 | HARVONI (Sofosbuvir/Ledipasvir) | GILEAD SCIENCES | CANADA |
| GASTROENTEROLOGY | 2016 | ENTYVIO (Vedolizumab) | TAKEDA | CANADA |
| PHARMACOLOGY | 2015 | Works the pharmacological targets for brain diseases and cardiovascular diseases | Dr De Bock, Dr Decrock and Dr Wang | BELGIUM |
| ONCOLOGY | 2016 | NIVOLUMAB (Opdivo) | B.M.S. | BELGIUM |
| ONCOLOGY | 2016 | PEMBROLIZUMAB (Keytruda) | MERCK | BELGIUM |
| MEDICAL TECHNOLOGY | 2015 | S-ICD EMBLEM | Boston Scientific | BELGIUM |
| ONCOLOGY | 2016 | Ibrance (palbociclib) | Pfizer | BELGIUM |
| PHARMACOLOGY | 2016 | Julien Hanson for work on G-protein coupled receptors | University of Liège | BELGIUM |
| MEDICAL TECHNOLOGY | 2016 | Idylla™ NRAS-BRAF | Biocartis | BELGIUM |
| ONCOLOGY | 2015 | NIVOLUMAB (Opdivo) | B.M.S. | USA |
| ONCOLOGY | 2015 | PEMBROLIZUMAB (Keytruda) | MERCK | USA |
| MEDICAL TECHNOLOGY | 2015 | T2Candida Pane | T2 BIOSYSTEMS | USA |
| HEMATOLOGY | 2015 | IBRUTINIB (Imbruvica) | JANSSEN | USA |
| HEMATOLOGY | 2015 | BRENTUXIMAB (Adcetris) | TAKEDA | SWITZERLAND |
| VACCINOTHERAPY | 2015 | 6-in-1 infant vaccine | SANOFI-PASTEUR | POLAND |
| ONCOLOGY | 2015 | Treatment of caustic oesophageal stenosis by a removable stent | Pr Marek Woynarowski (Institut Memorial Health The Children) | POLAND |
| ONCOLOGY | 2015 | PERTUZUMAB (Perjeta) | ROCHE | POLAND |
| ONCOLOGY | 2015 | NIVOLUMAB (Opdivo) | B.M.S. | POLAND |
| MEDICAL TECHNOLOGY | 2015 | CyberOko - diagnosis and treatment of comatose states | Pr Andrzej Czyzewski (université de Gdańsk) | POLAND |
| DERMATOLOGY | 2015 | Works on Supporting Polymer | CENTRE DES MATERIAUX DE POLYMERE ET DE CARBONE-ACADEMIE POLONAISE DES SCIENCES-PAN | POLAND |
| PNEUMOLOGY | 2015 | BEDAQUILINE (Sirturo) | JANSSEN | NETHERLANDS |
| PHARMACOLOGY | 2015 | Works on the personalization of dosages according to the populations in reaction to drugs pharmacokinetics and pharmacodynamics. | Dr. A. Huitema | NETHERLANDS |
| ONCOLOGY | 2015 | PEMBROLI ZUMAB (Keytruda) | MERCK MSD | ITALY |
| ONCOLOGY | 2015 | OPDIVO (Nivolumab) | Bristol-Myers Squibb | ITALY |
| RHUMATOLOGY | 2015 | All work in rheumatology | Dr Kollias, centre de recherche Alexander Flemming | GREECE |
| ONCOLOGY | 2015 | VISMODEGIB (Erivedge) | ROCHE HELLAS | GREECE |
| ONCOLOGY | 2015 | DENOSUMAB (XGEVA) | AMGEN | GREECE |
| MEDICAL TECHNOLOGY | 2015 | MIYABI medical imaging diagnostic | SIEMENS HEALTHCARE HELLAS | GREECE |
| HEPATOLOGY, GASTRO ENTEROLOGY | 2015 | SOFOSBUVIR (SOVALDI) | GILEAD HELLAS | GREECE |
| CARDIOLOGY | 2015 | MACITENTAN (OPSUMIT) | ACTELION PHARMACEUTICALS HELLAS | GREECE |
| PHARMACOLOGY | 2015 | Works on the study of capsaicin receptors TRPV1 | Pr Siemens | GERMANY |
| ONCOLOGY | 2015 | RADIUM 223 DICHLORID (Xofigo) | BAYER HEALTHCARE | GERMANY |
| ADDICTOLOGY | 2015 | NALMEFENE (Selingro) | LUNDBECK | GERMANY |
| ONCOLOGY | 2015 | IBRUTINIB (Imbruvica) | Janssen Biotech, Inc. & Pharmacyclics LLC, and AbbVie Company | FRANCE |
| ONCOLOGY | 2015 | AFATINIB (Giotrif) | BOEHRINGER-INGELHEIM | CANADA |
| HEMATOLOGY | 2015 | Works on possible treatments for heparin-induced thrombocytopenia. | Drs Kelton et Warkentin (universit McMaster) | CANADA |
| ONCOLOGY | 2015 | Works on bioavailable oral inhibitor of fibroblast activation protein (FAP) | Pr Van der Veken (Universiteit Antwerpen) | BELGIUM |
| VACCINOTHERAPY | 2014 | ZOSTAVAX, Zoster | MERCK | USA |
| MEDICAL TECHNOLOGY | 2014 | Provue Retriever (Trevo) | STRYKER | USA |
| MEDICAL TECHNOLOGY | 2014 | Subcutaneous implantation defibrillator (S-ICD system) | Boston Scientific | USA |
| INFECTIOLOGY | 2014 | SOFOSBUVIR (Solvadi) | GILEAD SCIENCES | USA |
| INFECTIOLOGY | 2014 | PIRFENIDONE (Esbriet) | INTERMUNDE | USA |
| BIOTECHNOLOGY | 2014 | Cord Blood (Hemacord) | New York Blood Center Howard Milstein | USA |
| VACCINOTHERAPY | 2014 | BEXSERO | NOVARTIS | UNITED KINGDOM |
| PNEUMOLOGY | 2014 | IVACAFTOR (Kalydeco) | VERTEX PHARMACEUTICALS | UNITED KINGDOM |
| NEUROLOGY | 2014 | FINGOLIMOD (Gilenya) | NOVARTIS | SWITZERLAND |
| VACCINOTHERAPY | 2014 | PREVENAR 13, pneumococcal polysaccharide | PFIZER | RUSSIA |
| MEDICAL TECHNOLOGY | 2014 | Diaskintest | GENERIUM | RUSSIA |
| MEDICAL TECHNOLOGY | 2014 | Cobas HPV Test (detection of oncogenic papillomaviruses) | ROCHE DIAGNOSTICS | RUSSIA |
| CARDIOLOGY | 2014 | TICAGRETOL (Brilinta) | ASTRA-ZENECA | RUSSIA |
| VACCINOTHERAPY | 2014 | BEXSERO | NOVARTIS | POLAND |
| INFECTIOLOGY | 2014 | SOFOSBUWIR (Solvadi) | GILEAD SCIENCES | POLAND |
| HEMATOLOGY | 2014 | BRENTUXIMAB (Adcetris) | TAKEDA | POLAND |
| ONCOLOGY | 2014 | Identification of targets and markers in brain tumors | Dr. Tom Wrdinger, Pr Ren Bernards, Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL) | NETHERLANDS |
| VACCINOTHERAPY | 2014 | BEXSERO | NOVARTIS | ITALY |
| ONCOLOGY | 2014 | Works on stem cell transplantation in dystrophic muscles. | Dr Giannotta, Istituto FIRC di Oncologia Molecolare (IFOM), Milano | ITALY |
| PNEUMOLOGY | 2014 | BEDAQUILINE (Sirturo) | JANSSEN | GERMANY |
| NEUROLOGY | 2014 | DIMETHYLFUMARAT (Tecfidera) | BIOGEN IDEC | GERMANY |
| NEPHROLOGY | 2014 | Role of the immune system in kidney disease | Dr. Sker et Pr Zippel, Universit Jena Leibniz-Institut | GERMANY |
| INFECTIOLOGY | 2014 | SOFOSBUVIR (Solvadi) | GILEAD SCIENCES | GERMANY |
| RHUMATOLOGY | 2014 | CANAKITUMAB (Ilaris) | NOVARTIS | FRANCE |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2014 | ORPHACOL (cholic acid) | CTRS | FRANCE |
| DERMATOLOGY | 2014 | PROPANOLOL (Hemangiol) | PIERRE FABRE DERMATOLOGIE | FRANCE |
| CARDIOLOGY | 2014 | Identification of therapeutic targets and new compounds in hypertension and heart failure | Dr Catherine Llorens-Cortes, Collge de France | FRANCE |
| PNEUMOLOGY | 2014 | PIRFERIDONE (Esbriet) | ROCHE-INTERMUNDE | CANADA |
| INFECTIOLOGY | 2014 | Work in microbiology, pharmacology, vaccine development | Dr Finlay | CANADA |
| INFECTIOLOGY | 2014 | Work on HIV | Dr Plummer | CANADA |
| ONCOLOGY | 2014 | TRASTUZUMAB EMTANSIN T-DM1 (Kadcyla) | ROCHE | BELGIUM |
| ONCOLOGY | 2013 | VEMURAFENIB (Zelboraf) | ROCHE | USA |
| ONCOLOGY | 2013 | ZELBORAF (vemurafenib) | GENRENTCH | USA |
| VACCINOLOGY | 2013 | ZOSTAVAX (Zoster Vaccine Live) | MERCK | USA |
| ONCOLOGY | 2013 | VEMURAFENIB (Zelboraf) | ROCHE | SWITZERLAND |
| PHARMACOLOGY | 2013 | Works on nanomodular transmitters | Pr Sobolev, Pr Rosenkranz, Pr Lunin | RUSSIA |
| OPHTHALMOLOGY | 2013 | RANIBIZUMAB (Lucentis) | NOVARTIS | RUSSIA |
| HEMATOLOGY | 2013 | BRENTUXIMAB (Adcetris) | PFIZER | RUSSIA |
| PNEUMOLOGY | 2013 | IVACAFTOR (Kalydeco) | VERTEX PHARMACEUTICALS | NETHERLANDS |
| ONCOLOGY | 2013 | PEMETREXED (Alimta) | ELI LILLY | NETHERLANDS |
| BIOCHEMISTRY | 2013 | Biomimetic support systems for biotherapeutics | Pr Mastrobattista, université d’Ultrech | NETHERLANDS |
| PNEUMOLOGY | 2013 | IVACAFTOR (Kalydeco) | VERTEX PHARMACEUTICALS | INTERNATIONAL |
| RHUMATOLOGY | 2013 | TOCILIZUMAB (Roactemra) | ROCHE | GREECE |
| NEUROLOGY | 2013 | FINGOLIMOD (Gilenya) | NOVARTIS | GREECE |
| MEDICAL TECHNOLOGY | 2013 | Cobas HPV Test (detection of oncogenic papillomaviruses) | ROCHE DIAGNOSTICS | GREECE |
| HEMATOLOGY | 2013 | PLERIXAFOR (Mozobil) | SANOFI | GREECE |
| HEMATOLOGY | 2013 | ROMIPLOSTIM (nPlate) | AMGEN | GREECE |
| PNEUMOLOGY | 2013 | IVACAFTOR (Kalydeco) | VERTEX PHARMACEUTICALS | GERMANY |
| ONCOLOGY | 2013 | PERTUZUMAB (Perjeta) | ROCHE | GERMANY |
| ONCOLOGY | 2013 | VEMURAFENIB (Zelboraf) | ROCHE | GERMANY |
| NEPHROLOGY | 2013 | Works on the ACE therapeutic inhibitor on Alport syndrome | Pr Dr Gross | GERMANY |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2013 | RIFAXIMIN (Xifaxan) | NORGINE GmBH | GERMANY |
| VACCINOTHERAPY | 2013 | BEXSERO | NOVARTIS VACCINS | FRANCE |
| PNEUMOLOGY | 2013 | IVACAFTOR (Kalydeco) | VERTEX PHARMACEUTICALS | FRANCE |
| INFECTIOLOGY | 2013 | Modeling of antiviral hepatitis C therapy | Pr Baumert | FRANCE |
| ONCOLOGY | 2013 | IPILIMUMAB (Yervoy) | B.M.S. | CANADA |
| ONCOLOGY | 2013 | CRIZOTINIB (Xalkori) | PFIZER | BELGIUM |
| ONCOLOGY | 2013 | Targets and tools on lymphoid tumors | Pr Geert Bultync (KULeuven) | BELGIUM |
| ONCOLOGY | 2012 | YERVOY (ipilimumab) | B.M.S. | USA |
| MEDICAL TECHNOLOGY | 2012 | Sapien3 Transcatheter Heart valve | EDWARDS LIFESCIENCES | USA |
| MEDICAL TECHNOLOGY | 2012 | Melody Transcatheter Pulmonary valve (RPV) Therapy (Metrotonic) | MEDTRONIC | USA |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | USA |
| INFECTIOLOGY | 2012 | BOCEPREVIR (Victrelis) | MERCK MSD | USA |
| ONCOLOGY | 2012 | INN-MIFAMURTIDE (Mepact) | TAKEDA | UNITED KINGDOM |
| INFECTIOLOGY | 2012 | BOCEPREVIR (Victrelis) | MERCK MSD | UNITED KINGDOM |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | UNITED KINGDOM |
| RHUMATOLOGY | 2012 | DENOSUMAB (Prolia) | AMGEN/GSK | SWITZERLAND |
| VACCINOTHERAPY | 2012 | PREVENAR 13, pneumococcal polysaccharide | PFIZER | POLAND |
| MEDICAL TECHNOLOGY | 2012 | Development of an electronic chip | Institut STUCHU | POLAND |
| MEDICAL TECHNOLOGY | 2012 | Development of computer-based clinical studies for pulmonary and cardiac diseases | Institut PAN | POLAND |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | POLAND |
| INDUSTRIAL RESEARCH | 2012 | Computerized clinical studies of pulmonary and cardiological diseases | Institut PAN | POLAND |
| CARDIOLOGY | 2012 | DABIGATRAN (Pradaxa) | BOEHRINGER INGELHEIM | POLAND |
| ONCOLOGY | 2012 | CATUMAXOMAB (Removab) | FRESENIUS BIOTECH | NETHERLANDS |
| CARDIOLOGY | 2012 | Regulation of genetic mechanisms in heart failure | Pr dr de Windt, MUNC | NETHERLANDS |
| ONCOLOGY | 2012 | IFOM Foundation, IFRC Institute for Molecular Oncology | SOFIA FRANCIA | ITALY |
| NEUROPSYCHIATRY | 2012 | AGOMELATINE (Valdoxan) | SERVIER | ITALY |
| NEUROLOGY | 2012 | FINGOLIMOD (Gilenya) | NOVARTIS | ITALY |
| NEUROLOGY | 2012 | USTEKINUMAB (Stelara) | JANSSEN BIOTECH | INTERNATIONAL |
| ONCOLOGY | 2012 | VEMURAFENIB (Zelboraf) | ROCHE | GERMANY |
| ONCOLOGY | 2012 | Works on Metastatic Cancer | Dr Worzfeld(Institut Max-Planck, Bad-Nauheim) | GERMANY |
| NEUROLOGY | 2012 | FINGOLIMOD (Gilenya) | NOVARTIS | GERMANY |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | FRANCE |
| INFECTIOLOGY | 2012 | BOCEPREVIR (Victrelis) | MERCK MSD | FRANCE |
| IMMUNOLOGY | 2012 | Development of antiviral vectors | Pr Hacein-bey Abina | FRANCE |
| BIOCHEMISTRY | 2012 | Works on ion channels | Pr Lazdunski | FRANCE |
| INFECTIOLOGY | 2012 | Works on antibiotic resistance | Dr Hankok | CANADA |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | CANADA |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | CANADA |
| INFECTIOLOGY | 2012 | BOCEPREVIR (Victrelis) | MERCK MSD | BELGIUM |
| INFECTIOLOGY | 2012 | TELAPREVIR (Incivo) | JANSSEN | BELGIUM |
| CARDIOLOGY | 2012 | Importance of von Willebrand Factor in the cerebrovascular accident | Pr de Meyer (KULeuven | BELGIUM |
| VACCINOTHERAPY | 2011 | ROTATEQ, rotavirus vaccine | SANOFI-PASTEUR-M.S.D. | USA |
| VACCINOTHERAPY | 2011 | PREVENAR 13 pneumococcal polysaccharide | PFIZER | USA |
| RHUMATOLOGY | 2011 | DENOSUMAB (Prolia) | AMGEN | USA |
| NEUROLOGY | 2011 | USTEKINUMAB (Stelara) | JANSSEN BIOTECH | USA |
| CARDIOLOGY | 2011 | IVABRADINE (Procoralan) | SERVIER | SWITZERLAND |
| PUBLIC HEALTH | 2011 | Phamaco-epidemiology work | Dr Ramon Laporte Rosello | SPAIN |
| HEMATOLOGY | 2011 | PLERIXAFOR (Mozobil) | GENZYME | SPAIN |
| HEMATOLOGY | 2011 | OFATUMUMAB (Arzerra) | GSK | NETHERLANDS |
| BIOCHEMISTRY | 2011 | Molecular Design and Chemical Synthesis | Dr de Esch | NETHERLANDS |
| UROLOGY | 2011 | Role of ciliary activity on mTOR inhibition | Pr Khn | GERMANY |
| RHUMATOLOGY | 2011 | DENOSUMAB (Prolia) | AMGEN/GSK | GERMANY |
| HEMATOLOGY | 2011 | ROMIPLOSTIM (nPlate) | AMGEN | GERMANY |
| VACCINOTHERAPY | 2011 | IXIARO, Japanese encephalitis vaccine | NOVARTIS. VACCINS. | FRANCE |
| RHUMATOLOGY | 2011 | TOCILIZUMAB (Roactemra) | ROCHE | FRANCE |
| HEMATOLOGY | 2011 | Human Fibrinogen (Clottafact) | LFB | FRANCE |
| CARDIOLOGY | 2011 | DABIGATRAN (Pradaxa) | BOEHRINGER INGELHEIM | CANADA |
| RHUMATOLOGY | 2011 | DENOSUMAB (Prolia) | AMGEN | BELGIUM |
| ONCOLOGY | 2011 | Role of chimokines and their use as markers | Pr Struyf (Institut Rega, universit royale de Louvain) | BELGIUM |
| INFECTIOLOGY | 2010 | COARTEM (Artemether-lumefantrine) | NOVARTIS | USA |
| CARDIOLOGY | 2010 | RIVAROXABAN (Xarelto) | PHARMA | UNITED KINGDOM |
| ALLERGOLOGY | 2010 | ACETATE ICATIBANT (Firazyr) | SHIRE PHARMACEUTICALS | UNITED KINGDOM |
| CARDIOLOGY | 2010 | RIVAROXABAN (Xarelto) | PHARMA | SWITZERLAND |
| HEMATOLOGY | 2010 | ROMIPLOSTIM (nPlate) | AMGEN | SPAIN |
| FORENSIC GENETICS | 2010 | Forensic medicine, extended to clinical genetics and medical genomics | Dr. M. Carracedo lvarez | SPAIN |
| UROLOGY | 2010 | Role of ABC carriers in renal failure | Dr Masereeuw | NETHERLANDS |
| HEMATOLOGY | 2010 | ROMIPLOSTIM (nPlate) | AMGEN | NETHERLANDS |
| VACCINOTHERAPY | 2010 | GARDASIL, papillomavirus vaccine | SANOFI-PASTEUR-M.S.D. | ITALY |
| HEMATOLOGY | 2010 | ROMIPLOSTIM (nPlate) | AMGEN | INTERNATIONAL |
| CARDIOLOGY | 2010 | RIVAROXABAN (Xarelto) | PHARMA | INTERNATIONAL |
| ONCOLOGY | 2010 | CATUMAXOMAB (Removab) | FRESENIUS BIOTECH | GERMANY |
| CARDIOLOGY | 2010 | New type of autophosphorylation ERK causing cardiac hypertrophy | Dr Lorenz, universit Wrzburg | GERMANY |
| CARDIOLOGY | 2010 | DABIGATRAN (Pradaxa) | BOEHRINGER INGELHEIM | GERMANY |
| HEMATOLOGY | 2010 | AZACITIDINE (Vidaza) | CELGENE | FRANCE |
| HEMATOLOGY | 2010 | RIVAROXABAN (Xarelto) | BAYER SCHERING | FRANCE |
| HEMATOLOGY | 2010 | ROMIPLOSTIM (nPlate) | AMGEN | FRANCE |
| CARDIOLOGY | 2010 | RIVAROXABAN (Xarelto) | PHARMA | FRANCE |
| NEUROLOGY | 2010 | USTEKINUMAB (Stelara) | JANSSEN BIOTECH | CANADA |
| INFECTIOLOGY | 2010 | Work on HIV | Dr J. Montaner | CANADA |
| RHUMATOLOGY | 2010 | TOCILIZUMAB (Roactemra) | ROCHE | BELGIUM |
| ONCOLOGY | 2010 | Development of a specific vasodilator of tumor vessels treatment | Pr Sonveaux (universit de Louvain) | BELGIUM |
| ONCOLOGY | 2009 | IMATINIB (Glivec) | NOVARTIS | USA |
| HEMATOLOGY | 2009 | ELTROMBOPAG (Promacta) | GSK | USA |
| HEMATOLOGY | 2009 | ROMIPLOSTIM (nPlate) | AMGEN | USA |
| VACCINOTHERAPY | 2009 | CERVARIX, papillomavirus vaccine | GLAXOSMITHKLINE | UNITED KINGDOM |
| RHUMATOLOGY | 2009 | ABATACEPT (Orencia) | BMS | SWITZERLAND |
| ONCOLOGY | 2009 | TRABECTIDINE (YONDELIS) | PHARMAPHARM | SPAIN |
| HEMATOLOGY | 2009 | Works on cellular lymphomas | Dr Campo, universit Barcelone | SPAIN |
| PHARMACOLOGY | 2009 | Works on nanoparticles and siRN | Dr Schiffeler | NETHERLANDS |
| INFECTIOLOGY | 2009 | RALDEGRAVIR (Insentress) | MERCK MSD-CHIBRET | ITALY |
| BIOCHEMISTRY | 2009 | Biochemistry works | Pr De Marco | ITALY |
| NEUROLOGY | 2009 | NITISINON (Orfadin) | SWEDISH ORPHAN INTERNATIONAL | GERMANY |
| CARDIOLOGY | 2009 | IVABRADINE (Procoralan) | SERVIER | GERMANY |
| PHARMACOLOGY | 2009 | Works on squalination | Pr Couvreur | FRANCE |
| HEMATOLOGY | 2009 | ECULIZUMAB (Soliris) | ALEXION | FRANCE |
| 2009 | NATALIZUMAB (Tygasi) | BIOGEN IDEC | FRANCE | |
| PUBLIC HEALTH | 2009 | VARENICLINE (Champix) | PFIZER | CANADA |
| NEUROLOGY | 2009 | Work on the treatment of epilepsy and Alzheimer's | Dr D.F. Weaver | CANADA |
| INFECTIOLOGY | 2009 | Work on Gram-negative infections | Dr D.F. Weaver | CANADA |
| PHARMACOLOGY | 2009 | Neonatal pharmacology work | Pr Allegaert | BELGIUM |
| HEMATOLOGY | 2009 | RIVAROXABAN (Xarelto) | BAYER SCHERING | BELGIUM |
| CARDIOLOGY | 2009 | RIVAROXABAN (Xarelto) | BAYER SCHERING | BELGIUM |
| RHUMATOLOGY | 2008 | RhBMP (Infuse) | WYETH | USA |
| INFECTIOLOGY | 2008 | RALDEGRAVIR (Insentress) | MERCK MSD-CHIBRET | USA |
| INFECTIOLOGY | 2008 | MARAVIROC (Selzentry) | PFIZER | USA |
| HEMATOLOGY | 2008 | ECULIZUMAB (Soliris) | ALEXION | USA |
| HEMATOLOGY | 2008 | Development of LENALIDOMIDE (Revlimid) | CELGENE | USA |
| VACCINOTHERAPY | 2008 | GARDASIL, papillomavirus vaccine | SANOFI-PASTEUR-M.S.D. | UNITED KINGDOM |
| HEMATOLOGY | 2008 | DEFERASIROX (Exjade) | NOVARTIS | UNITED KINGDOM |
| VACCINOTHERAPY | 2008 | GARDASIL, papillomavirus vaccine | SANOFI-PASTEUR-M.S.D. | SWITZERLAND |
| VACCINOTHERAPY | 2008 | GARDASIL, papillomavirus vaccine | SANOFI-PASTEUR-M.S.D. | SPAIN |
| INDUSTRIAL RESEARCH | 2008 | Animal models used in medical experimentation | Pr Desco | SPAIN |
| CARDIOLOGY | 2008 | IVABRADINE (Procoralan) | SERVIER | SPAIN |
| ENDOCRINOLOGY | 2008 | SITAGLIPTINE (Januvia) | MERCK MSD-CHIBRET | NETHERLANDS |
| INDUSTRIAL RESEARCH | 2008 | Industrial Research | D.sa Diana Bracco | ITALY |
| CARDIOLOGY | 2008 | IVABRADINE (Procoralan) | SERVIER | ITALY |
| VACCINOTHERAPY | 2008 | GARDASIL, papillomavirus vaccine | SANOFI-PASTEUR-M.S.D. | INTERNATIONAL |
| ONCOLOGY | 2008 | SORAFENID (Nexavar) | BAYER SCHERING PHARMA | FRANCE |
| NEUROLOGY | 2008 | STIRIPENTOL (Diacomit) | BIOCODEX | FRANCE |
| INFECTIOLOGY | 2008 | RALDEGRAVIR (Insentress) | MERCK MSD-CHIBRET | FRANCE |
| CARDIOLOGY | 2008 | IVABRADINE (Procoralan) | SERVIER | FRANCE |
| VACCINOTHERAPY | 2008 | GARDASIL, papillomavirus vaccine | SANOFI-PASTEUR-M.S.D. | CANADA |
| ENDOCRINOLOGY | 2008 | Works on the biological actions of the GLP-1 hormone | Dr Drucker | CANADA |
| OPHTHALMOLOGY | 2008 | RANIBIZUMAB (Lucentis) | NOVARTIS | BELGIUM |
| VACCINOTHERAPY | 2007 | ROTATEQ, rotavirus vaccine | SANOFI-PASTEUR-M.S.D. | USA |
| PUBLIC HEALTH | 2007 | VARENICLINE (Champix) | PFIZER | USA |
| INFECTIOLOGY | 2007 | Development of ivermectin | Pr Vagelos | USA |
| HEMATOLOGY | 2007 | HUMIRA (adalimumab) | ABBOTT | USA |
| ENDOCRINOLOGY | 2007 | SITAGLIPTINE (Januvia) | MERCK | USA |
| ONCOLOGY | 2007 | SUNITINIB (Sutent) | PFIZER | SWITZERLAND |
| PHARMACOLOGY | 2007 | Works on infectious diseases | Pr Bouza | SPAIN |
| VACCINOTHERAPY | 2007 | ROTATEQ, rotavirus vaccine | SANOFI-PASTEUR-M.S.D. | NETHERLANDS |
| PHARMACOLOGY | 2007 | Works on protein interferences | Pr Costenbrink | NETHERLANDS |
| PHARMACOLOGY | 2007 | Pharmacovigilance assessment work | Dr Martini | ITALY |
| NEUROLOGY | 2007 | Works on Pain | Pr Tiengo | ITALY |
| INFECTIOLOGY | 2007 | TIGECYCLINE (Tigacyl) | WYETH-LEDERLE | ITALY |
| BIOCHEMISTRY | 2007 | Works on biliverdine reductase in pathologies induced by free radicals | Dr Mancuso | ITALY |
| PNEUMOLOGY | 2007 | Importance of TRPC6 in alveolar pulmonary vasoconstriction | Priv.-Doz. Dr Dietrich etPr Dr Weismann | GERMANY |
| VACCINOTHERAPY | 2007 | GARDASIL, papillomavirus vaccine | SANOFI-PASTEUR-M.S.D. | FRANCE |
| PHARMACOLOGY | 2007 | Works on hepatocytes | Pr Guillouzo | FRANCE |
| ONCOLOGY | 2007 | CETUXIMAB (Erbitux) | MERCK -SERONO | FRANCE |
| PHARMACOLOGY | 2007 | Works on genetics and pharmacogenetics | Dr Hayden | CANADA |
| VACCINOTHERAPY | 2007 | GARDASIL, papillomavirus vaccine | SANOFI-PASTEUR-M.S.D. | BELGIUM |
| BIOCHEMISTRY | 2007 | Works on Tyrosine Kinase Inhibitors | Pr Cools | BELGIUM |
| VACCINOTHERAPY | 2006 | ROTARIX, rotavirus vaccine | GLAXOSMITHKLINE | UNITED KINGDOM |
| PNEUMOLOGY | 2006 | OMALIZUMAB (Xolair) | NOVARTIS PHARMA | UNITED KINGDOM |
| NEUROLOGY | 2006 | ALGLUCOSIDASE ALPHA (Myozyne) | GENZYME | UNITED KINGDOM |
| NEUROLOGY | 2006 | Works on hereditary and sporadic neuropathies | Pr Jos Angel Berciano Blanco | SPAIN |
| ONCOLOGY | 2006 | BEVACIZUMAB (Avastin) | PRODUITS ROCHE | NETHERLANDS |
| CARDIOLOGY | 2006 | Role of cholesterol in the development of atherosclerosis | Dr van Eck, universit de Leiden | NETHERLANDS |
| CARDIOLOGY | 2006 | EZETIMIDE / SIMVASTATIN (Ezetrol) | MSD –Essex | ITALY |
| ONCOLOGY | 2006 | BORTEZOMID (Velcade) | JANSSEN-CILAG | INTERNATIONAL |
| ONCOLOGY | 2006 | BEVACIZUMAB (Avastin) | PRODUITS ROCHE | FRANCE |
| NEUROPSYCHIATRY | 2006 | ARIPIPRAZOLE (Abilify) | BMS | FRANCE |
| VACCINOTHERAPY | 2006 | Works for the development of synthetic conjugated meningococcal vaccine | Dr Harold Jennings (Institut des sciences biologique du Conseil national de recherche scientifique) | CANADA |
| ONCOLOGY | 2006 | TRASTUZUMAB (Herceptin) | HOFMANN LA ROCHE | CANADA |
| INFECTIOLOGY | 2006 | PALIFERMINE (Kpivance) | AMGEN | BELGIUM |
| DERMATOLOGY | 2006 | PALIFERMIN (Kepivance) | AMGEN | BELGIUM |
| BIOCHEMISTRY | 2006 | Characterization of new receptors coupled to G proteins | Valrie Wittamer, universit libre de Bruxelles | BELGIUM |
| CARDIOLOGY | 2005 | EZETIMIDE (Ezetrol) | MSD –Essex | SWITZERLAND |
| ONCOLOGY | 2005 | CETUXIMAB (Erbitux) | MERCK PHARMA SPA | SPAIN |
| INFECTIOLOGY | 2005 | ATAZANAVIR (Reyataz) | BMS | SPAIN |
| BIOCHEMISTRY | 2005 | Works on the physiology of mother cells | Pr Martinez Alonso, universit Complutense, Madrid | SPAIN |
| ONCOLOGY | 2005 | BORTEZOMID (Velcade) | JANSSEN-CILAG | NETHERLANDS |
| RHUMATOLOGY | 2005 | ETANERCEPT (Enbrel) | WYETH-LEDERLE SPA | ITALY |
| ONCOLOGY | 2005 | CETUXIMAB (Erbitux) | MERCK PHARMA SPA | ITALY |
| PHARMACOLOGY | 2005 | Works on protein carriers | Drs Hauser et Grndemann | GERMANY |
| ONCOLOGY | 2005 | BORTEZOMID (Velcade) | JANSSEN-CILAG | GERMANY |
| TOXICOLOGY | 2005 | Works on and management of organophosphate toxicants | Service de Santé des Armes | FRANCE |
| RHUMATOLOGY | 2005 | STRONTIUM RANEL (Protelos) | SERVIER | FRANCE |
| ONCOLOGY | 2005 | BORTEZOMID (Velcade) | JANSSEN-CILAG | FRANCE |
| VACCINOTHERAPY | 2005 | Works in vaccinology and biotechnology | Dr Lorne Babiuk (universit de Saskatchewan) | CANADA |
| RHUMATOLOGY | 2005 | Research Works on inflammatory phenomena | VIRON THERAPEUTICS | CANADA |
| CARDIOLOGY | 2005 | Development of a model for the study of the of heart failure mechanism | Dr Amstrong, université d’Alberta | CANADA |
| ONCOLOGY | 2005 | BORTEZOMID (Velcade) | JANSSEN-CILAG | BELGIUM |
| VACCINOTHERAPY | 2004 | PREVENAR, pneumococcal polysaccharide | WYETH | UNITED KINGDOM |
| INFECTIOLOGY | 2004 | ENFUVIRTIDE (Fuzon) | PRODUITS ROCHE | UNITED KINGDOM |
| ONCOLOGY | 2004 | GEFITINIB (Iressa) | ASTRA-ZENECA | SWITZERLAND |
| NEUROLOGY | 2004 | MEMANTINE (Ebixa) | LUNDBECK | SPAIN |
| IMMUNOLOGY | 2004 | Works in immunology | Pr Martinez Alonso, universit Complutense, Madrid | SPAIN |
| INFECTIOLOGY | 2004 | ENFUVIRTIDE (Fuzon) | PRODUITS ROCHE | PORTUGAL |
| NEUROLOGY | 2004 | Action of Serotonin Antigens | Pr Dr Cremers | NETHERLANDS |
| INFECTIOLOGY | 2004 | ENFUVIRTIDE (Fuzon) | PRODUITS ROCHE | NETHERLANDS |
| PNEUMOLOGY | 2004 | Allergy research work | Pr Zanussi | ITALY |
| INFECTIOLOGY | 2004 | Meningococcal vaccine (Menjugate) | CHIRON | ITALY |
| INDUSTRIAL RESEARCH | 2004 | Industrial and academic research | Prs Sertini et Gavinaghi | ITALY |
| INFECTIOLOGY | 2004 | ENFUVIRTIDE (Fuzon) | PRODUITS ROCHE | INTERNATIONAL |
| PNEUMOLOGY | 2004 | BOSENTAN (Tracleer) | ACTELION | FRANCE |
| ONCOLOGY | 2004 | OXALIPLATINE (Eloxatin) | SANOFI-SYNTHELABO | FRANCE |
| INDUSTRIAL RESEARCH | 2004 | Research Institute | IPSEN | FRANCE |
| PNEUMOLOGY | 2004 | TIOTROPIUM (Spiriva) | BOEHRINGER | CANADA |
| INFECTIOLOGY | 2004 | ENFUVIRTIDE (Fuzon) | PRODUITS ROCHE | BELGIUM |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2004 | Works on alteration of the peritoneal membrane | Pr Devuyst | BELGIUM |
| VACCINOTHERAPY | 2003 | PREVENAR, pneumococcal polysaccharide | WYETH | SWITZERLAND |
| INFECTIOLOGY | 2003 | LINEZOLID (Zyvoxid) | PHARMACIA-PFIZER | SWITZERLAND |
| VACCINOTHERAPY | 2003 | PREVENAR, pneumococcal polysaccharide | WYETH | SPAIN |
| PNEUMOLOGY | 2003 | BOSENTAN (Tracleer) | ACTELION | PORTUGAL |
| INFECTIOLOGY | 2003 | DROTECOGINE (Xigris) | ELI LILLY | NETHERLANDS |
| CARDIOLOGY | 2003 | FONDAPARINUX (Arixtra) | SANOFI SYNTHELABO | ITALY |
| INFECTIOLOGY | 2003 | LINEZOLID (Zyvoxid) | PHARMACIA-PFIZER | GERMANY |
| DERMATOLOGY | 2003 | Effect of efomycin in psoriasis | Prs Boenecke et Schn | GERMANY |
| VACCINOTHERAPY | 2003 | PREVENAR, pneumococcal polysaccharide | WYETH | FRANCE |
| INFECTIOLOGY | 2003 | VORICONAZOLE (VFend) | PFIZER | FRANCE |
| ONCOLOGY | 2003 | GLEEVEC (imatinib) | NOVARTIS PHARMA | CANADA |
| INFECTIOLOGY | 2003 | Development of lamivudine (3TC) | Dr Wainberg | CANADA |
| PHARMACOLOGY | 2003 | New vision of intracellular communication | Pr Hermans | BELGIUM |
| INFECTIOLOGY | 2003 | DROTECOGINE (Xigris) | ELI LILLY | BELGIUM |
| ONCOLOGY | 2002 | TRASTUZUMAB (Herceptin) | ROCHE Products | UNITED KINGDOM |
| ONCOLOGY | 2002 | IMATINIB (Glivec) | NOVARTIS | UNITED KINGDOM |
| ONCOLOGY | 2002 | IMATINIB (Glivec) | NOVARTIS | SWITZERLAND |
| ONCOLOGY | 2002 | ZOLEDRONIC ACID (Zometa) | NOVARTIS | SPAIN |
| NEUROPSYCHIATRY | 2002 | Works on neurotransmitters action in neurodegenerative processes and psychiatric disorders | Pr del Rio Zambrana | SPAIN |
| ENDOCRINOLOGY | 2002 | ROSIGLITAZONE (Avandia) | GLAXOSMITHKINE | SPAIN |
| ONCOLOGY | 2002 | IMATINIB (Glivec) | NOVARTIS | PORTUGAL |
| ONCOLOGY | 2002 | IMATINIB (Glivec) | NOVARTIS | NETHERLANDS |
| RADIOLOGY | 2002 | DIMEGLUNIDE GADOLENATE (Multihance) | ALBANA PHARMA | ITALY |
| ONCOLOGY | 2002 | Identification of antitumor lymphocytes | Pr Moretta | ITALY |
| ONCOLOGY | 2002 | IMATINIB (Glivec) | NOVARTIS | ITALY |
| NEUROLOGY | 2002 | Pharmacology of neuropeptides | MENARINI, Pr Carlo Maggi | ITALY |
| ONCOLOGY | 2002 | IMATINIB (Glivec) | NOVARTIS | INTERNATIONAL |
| ONCOLOGY | 2002 | IMATINIB (Glivec) | NOVARTIS | FRANCE |
| INDUSTRIAL RESEARCH | 2002 | The whole research | SERVIER | FRANCE |
| RHUMATOLOGY | 2002 | ETANERCEPT (Enbrel) | WYETH-LEDERLE | CANADA |
| OPHTHALMOLOGY | 2002 | Works on photodynamic therapy | Drs Dolphin et Lvy | CANADA |
| ONCOLOGY | 2002 | IMATINIB (Glivec) | NOVARTIS | CANADA |
| PNEUMOLOGY | 2002 | Studies of leucocyte migration mechanism | Dr Blainpain | BELGIUM |
| ONCOLOGY | 2002 | IMATINIB (Glivec) | NOVARTIS | BELGIUM |
| PNEUMOLOGY | 2001 | Research on respiratory pathologies | Prs Morcillo et Cortijo | SPAIN |
| NEUROLOGY | 2001 | ALMOTRIPTAN (Almogran) | ALMIRALL-PRODESFARMA | SPAIN |
| OPHTHALMOLOGY | 2001 | VERTEPORFINE (Visudyne) | NOVARTIS | PORTUGAL |
| ONCOLOGY | 2001 | TRASTUZUMAB (Herceptin) | ROCHE | NETHERLANDS |
| BIOCHEMISTRY | 2001 | Simultaneous activation of angiogenesis and coagulation in oncology | Dr H.M. Werheul | NETHERLANDS |
| PNEUMOLOGY | 2001 | MOXIFLOXACINE (Avelox) | BAYER | ITALY |
| NEUROLOGY | 2001 | Action of serotonin receptors | Pr Genazziini | ITALY |
| INFECTIOLOGY | 2001 | MIOXIFLOXACINE (Avalox) | BAYER | ITALY |
| PNEUMOLOGY | 2001 | PALIVIZUMAB (Synagis) | ABBOTT | GERMANY |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2001 | Action of glycoproteins on the small intestine | Dr Eichelbaum | GERMANY |
| TOXICOLOGY | 2001 | METHYL-PYRAZOLE (Fomepizole) | AP-HP, ORPHAN | FRANCE |
| PHARMACOLOGY | 2001 | Identification of new molecules | Pr Schwartz | FRANCE |
| OPHTHALMOLOGY | 2001 | VERTEPORFINE (Visudyne) | NOVARTIS | FRANCE |
| UROLOGY | 2001 | SILDENAFIL CITRATE (Viagra) | PFIZER | CANADA |
| CARDIOLOGY | 2001 | Clinical trial methodologies | Dr Yusuf | CANADA |
| ONCOLOGY | 2001 | TRASTUZUMAB (Herceptin) | ROCHE | BELGIUM |
| VACCINOTHERAPY | 2000 | MENINGITEC, meningococcal vaccine | WYETH | UNITED KINGDOM |
| UROLOGY | 2000 | SILDENAFIL CITRATE (Viagra) | PFIZER | UNITED KINGDOM |
| VACCINOTHERAPY | 2000 | MENINGITEC, meningococcal vaccine | WYETH | SPAIN |
| ENDOCRINOLOGY | 2000 | RALOXIFENE (Evista) | LILLY | SPAIN |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2000 | INFLIXIMAB (Remicade) | MERCK SCHERING-PLOUGH | PORTUGAL |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2000 | INFLIXIMAB (Remicade) | MERCK SCHERING-PLOUGH | NETHERLANDS |
| RHUMATOLOGY | 2000 | ROFECOXIB (Vioxx) | MERCK-SHARP-DOHME | ITALY |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 2000 | INFLIXIMAB (Remicade) | MERCK SCHERING-PLOUGH | INTERNATIONAL |
| UROLOGY | 2000 | SILDENAFIL CITRATE (Viagra) | PFIZER | FRANCE |
| ONCOLOGY | 2000 | Farnesyltransferase Inhibitors | JANSSEN-CILAG | FRANCE |
| CARDIOLOGY | 2000 | CLOPIDOGREL (Plavix) | SANOFI-SYNTHELABO-BRISTOL-MYERS SQUIBB | FRANCE |
| PNEUMOLOGY | 2000 | MONTELUKAST (Singulair) | MERCK-FROSST | CANADA |
| RHUMATOLOGY | 2000 | ROFECOXIB (Vioxx) | MERCK-SHARP-DOHME | BELGIUM |
| RHUMATOLOGY | 2000 | ROFECOXIB (Vioxx) | MERCK-SHARP-DOHME | BELGIUM |
| NEUROLOGY | 2000 | Role of glutamate antagonists in epilepsy | Dr Smolders | BELGIUM |
| PNEUMOLOGY | 1999 | MONTELUKAST (Singulair) | MERCK-SHARP- DOHME | SPAIN |
| CARDIOLOGY | 1999 | Anti-ischemic activity | Pr Garcia | SPAIN |
| PNEUMOLOGY | 1999 | MONTELUKAST (Singulair) | MERCK-SHARP- DOHME | PORTUGAL |
| UROLOGY | 1999 | SILDENAFIL CITRATE (Viagra) | PFIZER | NETHERLANDS |
| IMMUNOLOGY | 1999 | BASILIXIMAB (Simulect) | NOVARTIS | ITALY |
| NEUROLOGY | 1999 | ACAMPROSATE (Campral) | MERCK | GERMANY |
| HEMATOLOGY | 1999 | Pre-eclampsia molecular mechanism | Hpital de la Charit Berlin | GERMANY |
| HEMATOLOGY | 1999 | RITUXIMAB (Mabthera) | ROCHE | FRANCE |
| CARDIOLOGY | 1999 | Lipoproteins metabolism | Pr Fruchart | FRANCE |
| CARDIOLOGY | 1999 | ATORVASTATIN (Lipitor) | PARKE-DAVIS | CANADA |
| CARDIOLOGY | 1999 | Treatment of venous thromboembolism | Dr. Hirsh | CANADA |
| PHARMACOLOGY | 1999 | New nucleotide receptors | Dr Commune | BELGIUM |
| HEMATOLOGY | 1999 | RITUXIMAB (Mabthera) | ROCHE | BELGIUM |
| CARDIOLOGY | 1999 | Characterization of new purinergic receptors | Dr Communi | BELGIUM |
| PNEUMOLOGY | 1998 | MONTELUKAST (Singulair) | MERCK-SHARP- DOHME | UNITED KINGDOM |
| OPHTHALMOLOGY | 1998 | Development of an antibody for wound healing | Cambridge Technology | UNITED KINGDOM |
| ONCOLOGY | 1998 | TOPOTECAN (Hycantin) | SMITHKLINE-BEECHAM | SPAIN |
| ONCOLOGY | 1998 | TRETINOINE (Vesanoid) | ROCHE | PORTUGAL |
| NEUROLOGY | 1998 | TOLCAPONE (Tasmar) | ROCHE | NETHERLANDS |
| NEUROLOGY | 1998 | Research works in neuropharmacology | Drs Mantegazza & Bagetta | ITALY |
| CARDIOLOGY | 1998 | LOSARTAN (Cozaar) | MERCK-SHARP-DOHME | ITALY |
| INFECTIOLOGY | 1998 | RITONAVIR | ABBOTT | INTERNATIONAL |
| INFECTIOLOGY | 1998 | INDINAVIR, | MSD | INTERNATIONAL |
| INFECTIOLOGY | 1998 | SAQUINAVIR | ROCHE | INTERNATIONAL |
| NEUROLOGY | 1998 | INTERFERON BETA 1A (Avonex) | BIOGEN | FRANCE |
| INDUSTRIAL RESEARCH | 1998 | Research Institute | PIERRE FABRE | FRANCE |
| ENDOCRINOLOGY | 1998 | FOLLITROPINE BETA (Purgon) | ORGANON | FRANCE |
| ENDOCRINOLOGY | 1998 | FOLLITROPINE ALPHA (Gonal F) | SERONO | FRANCE |
| RHUMATOLOGY | 1998 | ALENDRONATE (Fosamax) | MERCK-SHARP-DOHME | CANADA |
| ONCOLOGY | 1998 | IRINOTECAN (Campto) | RHONE-POULENC | BELGIUM |
| NEUROPSYCHIATRY | 1997 | ZYPREXA (Olanzapine) | ELI-LILLY | UNITED KINGDOM |
| INFECTIOLOGY | 1997 | SAQUINAVIR (Invirase) | ROCHE | SPAIN |
| CARDIOLOGY | 1997 | Antiarrhythmics action mechanism | Dr. Tamargo | SPAIN |
| BIOCHEMISTRY | 1997 | Opiates action mechanism | Dr. Florz | SPAIN |
| INFECTIOLOGY | 1997 | SAQUINAVIR (Invirase) | ROCHE | PORTUGAL |
| IMMUNOLOGY | 1997 | MYCOPHENOLATE-MOFETIL (Cellcept) | Produits ROCHE | NETHERLANDS |
| ENDOCRINOLOGY | 1997 | FOLLITROPINE (Provegon) | ORGANON | ITALY |
| CARDIOLOGY | 1997 | Cardiovascular Biotechnology | Prs. Giotti et Soma | ITALY |
| CARDIOLOGY | 1997 | LOSARTAN (Lorzaar) | MERCK-SHARP-DOHME | GERMANY |
| BIOCHEMISTRY | 1997 | Physiological role of cGMP in kinase protein | Dr.Pfeiffer | GERMANY |
| NEUROLOGY | 1997 | MODAFINIL (Modiodal) | LAFON | FRANCE |
| NEUROLOGY | 1997 | Research on Alzheimer's | Drs.Gautier, Poirier, Quirion | CANADA |
| INFECTIOLOGY | 1997 | EPIVIR (Lamivudine) | GLAXO-WELLCOME | CANADA |
| DERMATOLOGY | 1996 | ACICLOVIR (Zovirax) | GLAXOWELLCOME | UNITED KINGDOM |
| CARDIOLOGY | 1996 | LOSARTAN (Cozaar) | MERCK-SHARP-DOHME | SPAIN |
| ONCOLOGY | 1996 | DOCETAXEL (Taxotere) | RP-R | PORTUGAL |
| NEUROLOGY | 1996 | ACAMPROSATE (Campral) | MERCK | NETHERLANDS |
| NEUROPSYCHIATRY | 1996 | RISPERIDONE (Risperdal) | JANSSEN-CILAG | INTERNATIONAL |
| NEUROPSYCHIATRY | 1996 | RISPERIDONE (Risperdal) | JANSSEN-CILAG | FRANCE |
| NEUROLOGY | 1996 | Discovery of neuropeptide receptors | Drs Maffrand & Brelire SANOFI | FRANCE |
| NEUROPSYCHIATRY | 1996 | RISPERIDONE (Risperdal) | JANSSEN-CILAG | CANADA |
| NEUROLOGY | 1996 | VIGABATRINE (Sabril) | HOECHST-MARION-ROUSSEL | CANADA |
| INFECTIOLOGY | 1996 | Discovery of 3 TC (Lamivudine) | BIOCHEM-PHARMA | CANADA |
| INFECTIOLOGY | 1996 | INDINAVIR (Crixivan) | MERCK MSD | BELGIUM |
| INFECTIOLOGY | 1996 | RITONAVIR (Norway) | ABBOTT | BELGIUM |
| CARDIOLOGY | 1996 | Influence of NO-synthase on cardiac function | Dr. Balligand | BELGIUM |
| NEUROLOGY | 1995 | LAMOTRIGINE (Lamictal) | GLAXO-WELLCOME | UNITED KINGDOM |
| INFECTIOLOGY | 1995 | SAQUINAVIR (Invirase) | ROCHE | UNITED KINGDOM |
| ONCOLOGY | 1995 | PACLITAXEL (Taxol) | BMS | SPAIN |
| PNEUMOLOGY | 1995 | DORNASE ALPHA (Pulmozyme) | ROCHE | PORTUGAL |
| RHUMATOLOGY | 1995 | TENIDAP (Enablex) | PFIZER | NETHERLANDS |
| RADIOLOGY | 1995 | ECHOVIST | MERCK SCHERING | GERMANY |
| NEUROLOGY | 1995 | Discovery of new extraneuronal noradrenaline inhibitors | Prs. Pfeiffer,Schmig, Russ | GERMANY |
| PHARMACOLOGY | 1995 | Molecules modeling | Pr Roques | FRANCE |
| CARDIOLOGY | 1995 | Works on imidazoline receptors | Pr Bousquet | FRANCE |
| ANESTHESIA-REANIMATION | 1995 | PRILOCAINE-LIDOCAINE (Emla) | ASTRA | FRANCE |
| BIOCHEMISTRY | 1995 | Works on peptides | Dr Schiller | CANADA |
| NEUROLOGY | 1995 | INTERFERON BETA (Betaferon) | SCHERING AG. | BELGIUM |
| BIOCHEMISTRY | 1995 | Role of TGF-a in cell regeneration | Drs Lefebvre et Malgrange | BELGIUM |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 1994 | CIMETIDINE (Tagamet) | SKB | UNITED KINGDOM |
| VACCINOTHERAPY | 1994 | HAVRIX, hepatitis A vaccine | SMITHKLINE-BEECHAM | SPAIN |
| INDUSTRIAL RESEARCH | 1994 | All Research | PRODES-FARMA | SPAIN |
| CARDIOLOGY | 1994 | NADROPARINE CALCIUM (Fraxiparin) | SANOFI | PORTUGAL |
| HEMATOLOGY | 1994 | Antihemophilic Factor (Recombinate) | BAXTER | NETHERLANDS |
| HEMATOLOGY | 1994 | Role of glycoproteins on blood barrier | Dr Schinkel | NETHERLANDS |
| CARDIOLOGY | 1994 | Role of glycoproteins on blood barrier | Dr Schinkel | NETHERLANDS |
| UROLOGY | 1994 | Action of hormonal receptors in prostate cancer | Dr Sartani | ITALY |
| NEUROLOGY | 1994 | Discovery of serotonin | Pr Erspamer | ITALY |
| INFECTIOLOGY | 1994 | RIFABUTINE (Ansatipine, Farmacia) | Farmacia | ITALY |
| VACCINOTHERAPY | 1994 | PENTACOQ, PENTHIBEST, pentavalent vaccine | Inst.MERIEUX, PASTEUR VACCINS | FRANCE |
| ONCOLOGY | 1994 | Work in therapeutic oncology Vinorelbine, Taxotere | Pr Pierre Potier - CNRS | FRANCE |
| VACCINOTHERAPY | 1994 | HAVRIX, hepatitis A vaccine | SMITHKLINE-BEECHAM | EUROPE |
| NEUROLOGY | 1994 | SUMATRIPTAN (Imitrex) | GSK | CANADA |
| NEUROLOGY | 1994 | Role of dopaminergic receptors in schizophrenia etiology | Drs Seeman, Niznik,Van Tol | CANADA |
| ONCOLOGY | 1994 | PACLITAXEL (Taxol) | BMS | BELGIUM |
| CARDIOLOGY | 1994 | Synthesis of Torasemide Derivatives | Dr Masereel | BELGIUM |
| VACCINOTHERAPY | 1993 | HAVRIX, hepatitis A vaccine | SMITHKLINE BEECHAM | UNITED KINGDOM |
| DERMATOLOGY | 1993 | SERTACONAZOL (Sertol) | FERRER | SPAIN |
| PNEUMOLOGY | 1993 | SURFACTANT (Surfexo) | WELLCOME | PORTUGAL |
| CARDIOLOGY | 1993 | ILOMEDINE (Iloprost) | MERCK SCHERING | NETHERLANDS |
| VACCINOTHERAPY | 1993 | Anti-trauma recombinant vaccine | Dr Rappuoli | ITALY |
| CARDIOLOGY | 1993 | LACIDIPINE (Lacipin) | GSK | ITALY |
| VACCINOTHERAPY | 1993 | VACCINOL-HIB, anti-haemophilus influenzae B vaccine | ROHM-PHARMA | GERMANY |
| VACCINOTHERAPY | 1993 | HAVRIX, hepatitis A vaccine | SMITHKLINE BEECHAM | FRANCE |
| INDUSTRIAL RESEARCH | 1993 | Research Teams | SYNTHELABO | FRANCE |
| PHARMACOLOGY | 1993 | Identification of adenosine receptors, serotonin and thyrotropin | Dr Maenhaut | BELGIUM |
| DERMATOLOGY | 1993 | CALCIPOTRIOL (Daivonex) | LUNDBECK – LEO | BELGIUM |
| UROLOGY | 1992 | FINASTERIDE (Proscar) | MERCK MSD | UNITED KINGDOM |
| PNEUMOLOGY | 1992 | SURFACTANT (Exosurf) | WELLCOME | UNITED KINGDOM |
| ONCOLOGY | 1992 | ONDANSTRON (Zofren) | GSK | SPAIN |
| INDUSTRIAL RESEARCH | 1992 | All Research | URIACH | SPAIN |
| PNEUMOLOGY | 1992 | BERACTANT (Survanta) | ABBOTT | GERMANY |
| INFECTIOLOGY | 1992 | Collagen-Gentamycin combination | Pr Stemberger | GERMANY |
| IMMUNOLOGY | 1992 | CICLOSPORINE (Sandimmun) | SANDOZ | GERMANY |
| CARDIOLOGY | 1992 | New physiological approach to class F antiarrhythmics | Pr Weirich | GERMANY |
| ONCOLOGY | 1992 | FILGRASTIM (Neupogen) | AMGEN-ROCHE | FRANCE |
| INDUSTRIAL RESEARCH | 1992 | Research Team | JOUVEINAL - Dr Junien | FRANCE |
| ONCOLOGY | 1992 | FILGRASTIM (Neupogen) | AMGEN-ROCHE | EUROPE |
| VACCINOTHERAPY | 1992 | HAVRIX, hepatitis A vaccine | SMITHKLINE-BEECHAM | BELGIUM |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 1992 | Role of nitrous oxide in the gastrointestinal tract | Dr Boeckstaens | BELGIUM |
| ONCOLOGY | 1991 | FILGRASTIM (neupogen) | AMGEN-ROCHE | UNITED KINGDOM |
| ENDOCRINOLOGY | 1991 | OCTREOTIDE (Sandostatin) | SANDOZ | UNITED KINGDOM |
| CARDIOLOGY | 1991 | SIMVASTATIN (Zocor) | MERCK SHARP DOHME | UNITED KINGDOM |
| INDUSTRIAL RESEARCH | 1991 | All research | ESTEVE | SPAIN |
| CARDIOLOGY | 1991 | SIMVASTATIN (Zocor) | MERCK SHARP DOHME | SPAIN |
| INDUSTRIAL RESEARCH | 1991 | Research team for all of their work | LAFON | FRANCE |
| ENDOCRINOLOGY | 1991 | OCTREOTIDE (Sandostatin) | SANDOZ | FRANCE |
| CARDIOLOGY | 1991 | SIMVASTATIN (Zocor) | MERCK SHARP DOHME | EUROPE |
| ONCOLOGY | 1991 | FILGRASTIM (neupogen) | AMGEN-ROCHE | BELGIUM |
| ONCOLOGY | 1990 | ONDANSETRON (Zofran) | GSK | UNITED KINGDOM |
| ONCOLOGY | 1990 | ERYTHROPOIETINE (Eprex) | CILAG | UNITED KINGDOM |
| INDUSTRIAL RESEARCH | 1990 | All research | ALMIRALL | SPAIN |
| HEMATOLOGY | 1990 | ANISTREPTASE (Eminase) | BEECHAM | SPAIN |
| ONCOLOGY | 1990 | Study of cytostatics concentration | Pr Jens | GERMANY |
| DERMATOLOGY | 1990 | ACICLOVIR (Zovirax) | WELLCOME | GERMANY |
| RADIOLOGY | 1990 | Development of contrast products | GUERBET | FRANCE |
| PHARMACOLOGY | 1990 | Works on drug vectorization | Pr Puisieux - CNRS | FRANCE |
| ONCOLOGY | 1990 | ONDANSETRON (Zofran) | GSK | FRANCE |
| CARDIOLOGY | 1990 | SIMVASTATIN (Zocor) | MERCK MSD-CHIBRET | FRANCE |
| ONCOLOGY | 1990 | ONDANSETRON (Zofran) | GSK | EUROPE |
| PHARMACOLOGY | 1990 | Study on vasoactive substances derived from endothelium | Dr G.de Meyer | BELGIUM |
| ONCOLOGY | 1990 | ONDANSETRON (Zofran) | GSK | BELGIUM |
| NEUROLOGY | 1990 | Works on IUI | Prs Sies & Wendel | BELGIUM |
| BIOCHEMISTRY | 1990 | Study of vasoactive substances derived from endothelium | Dr G. de Meyer | BELGIUM |
| OPHTHALMOLOGY | 1989 | Works on the treatment of vitreous retinopathy | Dr Wiedemann | GERMANY |
| CARDIOLOGY | 1989 | Study of angiotensin | Dr Mann | GERMANY |
| ANESTHESIA-REANIMATION | 1989 | DANTROLENE (Dantrin) | ROHM-PHARMA | GERMANY |
| HEMATOLOGY | 1989 | RT-PA (Actilyse) | BOEHRINGER-INGELHEIM | FRANCE |
| DERMATOLOGY | 1989 | Study of antipsoriatics action mechanism | INSERM - Dr Dubertret | FRANCE |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 1989 | Pharmacology works on the gastric fundus innervation | Dr R.Lefebvre | BELGIUM |
| CARDIOLOGY | 1989 | SIMVASTATIN (Zocor) | MERCK SHARP DOHME | BELGIUM |
| VACCINOTHERAPY | 1988 | GENEVAX B, hepatitis B vaccine | MERCK MSD | GERMANY |
| RHUMATOLOGY | 1988 | Works on PAF antagonists | Dr Braquet -Inst.BEAUFOUR | FRANCE |
| NEUROPSYCHIATRY | 1988 | FLUMAZENIL (Anexate) | ROCHE | FRANCE |
| ONCOLOGY | 1988 | ERYTHROPOIETINE (Eprex) | CILAG | BELGIUM |
| NEUROLOGY | 1988 | Works on dopaminergic receptors | Dr de Keyser | BELGIUM |
| INFECTIOLOGY | 1987 | PRAZIQUANTEL (Cenaride Biltricide) | BAYER/MERCK-CLEVENOT | FRANCE |
| CARDIOLOGY | 1987 | Research team MILLOT-SOLAC Works on ticlopidine | SANOFI | FRANCE |
| VACCINOTHERAPY | 1987 | ENGERIX-B, hepatitis B vaccine | SKF | BELGIUM |
| HEMATOLOGY | 1987 | Works on ticlopidine | Drs Bechtold et Lhose | BELGIUM |
| CARDIOLOGY | 1987 | Research on muscarinic receptors | Pr Waelbroeck | BELGIUM |
| UROLOGY | 1986 | Study of furosemide | Drs Fuchs - Kolling | GERMANY |
| IMMUNOLOGY | 1986 | CICLOSPORINE (Sandimmun) | SANDOZ | GERMANY |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 1986 | History of antacids | Drs Engler & Postius | GERMANY |
| INFECTIOLOGY | 1986 | AMOXICILLIN-ACID-CLAVULANIC (Augmentin) | BEECHAM SEVIGNE | FRANCE |
| HEMATOLOGY | 1986 | Works on heparin and its fragments in trombo-embolic disease | Inst.CHOAY - Drs Choay-Lormeau et Petitou | FRANCE |
| ENDOCRINOLOGY | 1986 | Works on the diabetes etiology | SERVIER | BELGIUM |
| ANESTHESIA-REANIMATION | 1986 | ATRACURIUM (Tracrium) | WELLCOME | BELGIUM |
| UROLOGY | 1985 | Works on urokinase | Dr Gnzler | GERMANY |
| RHUMATOLOGY | 1985 | Discovery of a leukotriene | Dr Keppler | GERMANY |
| INFECTIOLOGY | 1985 | PRAZIQUANTEL (Cenaride Biltricide) | BAYER/MERCK-CLEVENOT | GERMANY |
| INFECTIOLOGY | 1985 | LAV Virus discovery | PASTEUR-Pr Montagnier | FRANCE |
| DERMATOLOGY | 1985 | ACICLOVIR (Zovirax) | WELLCOME | FRANCE |
| UROLOGY | 1985 | Study of renal phospholipidase | Dr Tulkens | BELGIUM |
| PNEUMOLOGY | 1985 | ASTEMIZOLE (Hismanal) | JANSSEN | BELGIUM |
| PNEUMOLOGY | 1985 | ALMITRINE (Vectarion) | SERVIER | BELGIUM |
| IMMUNOLOGY | 1984 | CICLOSPORINE (Sandimmun) | SANDOZ | FRANCE |
| DERMATOLOGY | 1984 | ETRETINATE (Tigason) | ROCHE | FRANCE |
| IMMUNOLOGY | 1984 | CICLOSPORINE (Sandimmun) | SANDOZ | BELGIUM |
| DERMATOLOGY | 1984 | Development of ketoconazole | Dr Janssen | BELGIUM |
| NEUROPSYCHIATRY | 1983 | Works on the Indalpine | PHARMUKA.MM Uzan & Le Fur | FRANCE |
| CARDIOLOGY | 1983 | CAPTOPRIL (Lopril) | SQUIBB | FRANCE |
| DERMATOLOGY | 1983 | ACICLOVIR (Zovirax) | WELLCOME | BELGIUM |
| ANESTHESIA-REANIMATION | 1983 | Works on anesthesia curarizers | Dr Hollander | BELGIUM |
| NEUROLOGY | 1982 | INOSINE-ACEDOBENE-DIMEPRAMOL (Isoprinosine) | DELALANDE | FRANCE |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 1982 | Works on timonium and its derivatives | RIOM-CERM-M.Bush | FRANCE |
| VACCINOTHERAPY | 1981 | Hepatitis B vaccine | FAC.TOURS - Pr Maupas | FRANCE |
| ANESTHESIA-REANIMATION | 1981 | NALOXONE (Narcan) | WINTHROP | FRANCE |
| CARDIOLOGY | 1980 | Works on almitrine | Dr Laubie | FRANCE |
| CARDIOLOGY | 1980 | NIFEDIPINE (Adalate) | BAYER | FRANCE |
| OPHTHALMOLOGY | 1979 | Works on timolol | MSD-CHIBRET Dr Le Douarec | FRANCE |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 1979 | CIMETIDINE (Tagamet) | SKB | FRANCE |
| INFECTIOLOGY | 1978 | LEVAMISOLE (Solaskil) | SPECIA | FRANCE |
| ENDOCRINOLOGY | 1978 | BROMOCRIPTINE (Parlodel) | SANDOZ | FRANCE |
| CARDIOLOGY | 1977 | Works on fenofibrate | FOURNIER - M.Majoie | FRANCE |
| VACCINOTHERAPY | 1976 | Meningococcal Vaccine | Inst.MERIEUX | FRANCE |
| NEUROPSYCHIATRY | 1976 | Works on sulpiride and metoclopramide | DELALANDE.MMThomi-net & Laville - Melle Margarit - | FRANCE |
| HEPATOLOGY, GASTRO-ENTEROLOGY | 1975 | CHENODESOXYCHOLIC ACID (Chenodex) | HOUDE | FRANCE |
| NEUROLOGY | 1974 | LEVODOPA (and carbidopa: Sinemet and benserazide: Modopar) | MSD-CHIBRET ROCHE | FRANCE |
| VACCINOTHERAPY | 1973 | Mutant influenza vaccine | Inst.PASTEUR Dr Hannoun | FRANCE |
| RHUMATOLOGY | 1973 | KETOPROFENE (Profenid) | SPECIA | FRANCE |
| CARDIOLOGY | 1972 | CLOFIBRATE (Lipavlon) | ICI-PHARMA | FRANCE |
| BIOCHEMISTRY | 1972 | Synthesis of daunorubicin hemi-synthetic derivatives | RHONE-POULENC Dr Maral, MM Jolls,Ponsinet | FRANCE |
| RHUMATOLOGY | 1971 | Direct Synthesis of A2 Prostaglandin | ROUSSEL Dr Martel | FRANCE |
| PNEUMOLOGY | 1971 | DISODIUM CROMOGLYCATE (Lomudal) | FISONS | FRANCE |
| INFECTIOLOGY | 1970 | RIFAMPICINE (Rifadine Rimactan) | LEPETIT CIBA | FRANCE |